Global Inhaled Nitric Oxide (iNO) Market – Analysis By Product Type, Application (ARDS, PPHN, Others), By Region, By Country (2020 Edition): Market Insights, COVID-19 Impact, Competition and Forecast (2020-2025)

Global Inhaled Nitric Oxide (iNO) Market – Analysis By Product Type, Application (ARDS, PPHN, Others), By Region, By Country (2020 Edition): Market Insights, COVID-19 Impact, Competition and Forecast (2020-2025)

Executive Summary

The Inhaled Nitric Oxide (iNO) Market was valued at USD 830.8 million in the year 2019. Over the recent years, Inhaled Nitric Oxide market has been witnessing considerable growth driven by increase in demand from healthcare, ongoing R&D activities leading to new application areas in healthcare industry, rising pollution levels and ever-growing aged population. Amongst geriatric population, there is a major prevalence of respiratory tract infections, tuberculosis, chronic obstructive pulmonary diseases, bronchial asthma and other several other diseases that will facilitate the growth of Inhaled Nitric Oxide Market. Several innovative technologies including Beyond Air’s LungFit device that is simple, cylinder free, plasma arc discharge-based technology likely to shape the Inhaled Nitric Oxide Market landscape in the future.

Among the Product Type in the Inhaled Nitric Oxide industry (99.92% Purity, 99.99% Purity, Others), the 99.92% Purity Product type are estimated to account for the largest share over the forecast period. Major factor which will drive the market for Inhaled Nitric Oxide is high per capita expenditure on healthcare, increase in number of hospitals, more preference towards branded treatment and drugs and high research funding.

The North America Inhaled Nitric Oxide Market will continue to be the largest market in the forecast period, majorly driven by large consumer base and increasing investment in research and development by the market players in the region. The countries such as Japan, China, United Kingdom, India are a lucrative market for Inhaled Nitric Oxide.

Scope of the Report

The report analyses the Inhaled Nitric Oxide (iNO) market by Value.
The report analyses the Inhaled Nitric Oxide Market By Product Type (99.92% Purity, 99.99% Purity, Others).
The report assesses the Inhaled Nitric Oxide Market By Application - ARDS (Acute Respiratory Distress Syndrome), PPHN (Persistent Pulmonary Hypertension in the Newborn) and Other Diseases.
The Global Inhaled Nitric Oxide Market has been analysed By Region (North America, Europe, Asia Pacific) and By Country (US, Canada, Mexico, UK, Italy, Germany, France, China, Japan, India).
The key insights of the report have been presented through ‘Market Attractiveness Charts’ presented by region, by product type, and by application. Also, the major opportunities, trends, drivers and challenges of the industry has been analysed in the report.
The report tracks competitive developments, strategies, mergers and acquisitions and new product development. The companies analysed in the report include Mallinckrodt Pharmaceuticals, Air Liquide S.A., Linde Plc (Praxair Inc.), Beyond Air Inc., NU-MED Plus, Inc., VERO Biotech LLC & Novoteris LLC.
The report presents the analysis of Inhaled Nitric Oxide market for the historical period of 2015-2019 and the forecast period of 2020-2025.

Key Target Audience

Inhaled Nitric Oxide Device Manufacturers
Pharmaceutical Companies
Consulting and Advisory Firms
Government and Policy Makers
Investment Banks and Equity Firms
Regulatory Authorities


1. Report Scope and Methodology
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary
2. Strategic Recommendations
3. Global Inhaled Nitric Oxide Market: Product Outlook
4. Global Inhaled Nitric Oxide Market: Sizing and Forecast
4.1 Market Size, By Value, Year 2015-2025
Table 1: Global Inhaled Nitric Oxide Market Size, By Value, 2015-2025 (USD Million)
Table 2: Healthcare Expenditure (Share of GDP), By Selected Country, 2013-2017 (In %)
Table 3: Deaths Due To Air Pollution, By Disease Type, 2016
Table 4: Percentage of NCD Cases Due to Air Pollution, 2016
Table 5: Global PM2.5 air pollution, mean annual exposure, 2012-2016
Table 6: Global Aged Population (Above 65), 2013-2017 (% of total)
Table 7: Global Aged Population (Above 65), By Country, 2017 (% of total)
5. Global Inhaled Nitric Oxide Market Segmentation By Product Type
5.1 Competitive Scenario of Global Inhaled Nitric Oxide Market – By Product Type
Table 8: Global Inhaled Nitric Oxide Market Share- By Product Type, 2019 & 2025
5.2 99.92% Purity – Market Size and Forecast (2020-2025)
Table 9: Global Inhaled Nitric Oxide Market- By 99.92% Purity, By Value (USD Million), 2015-2025
5.3 99.99% Purity - Market Size and Forecast (2020-2025)
Table 10: Global Inhaled Nitric Oxide Market- By 99.99% Purity, By Value (USD Million), 2015-2025
5.4 Others - Market Size and Forecast (2020-2025)
Table 11: Global Inhaled Nitric Oxide Market- By Others, By Value (USD Million), 2015-2025
6. Global Inhaled Nitric Oxide Market Segmentation By Application
6.1 Competitive Scenario of Global Inhaled Nitric Oxide Market– By Application
Table 12: Global Inhaled Nitric Oxide Market Share- By Application, 2019 & 2025
6.2 ARDS (Acute Respiratory Distress Syndrome)– Market Size and Forecast (2020-2025)
Table 13: Global Inhaled Nitric Oxide Market- By ARDS, By Value (USD Million), 2015-2025
6.3 PPHN (Persistent Pulmonary Hypertension of the Newborn)- Market Size and Forecast (2020-2025)
Table 14: Global Inhaled Nitric Oxide Market- By PPHN, By Value (USD Million), 2015-2025
6.4 Other Diseases- Market Size and Forecast (2020-2025)
Table 15: Global Inhaled Nitric Oxide Market- By Other Diseases, By Value (USD Million), 2015-2025
7. Global Inhaled Nitric Oxide Market: Regional Analysis
7.1 Competitive Scenario of Global Inhaled Nitric Oxide : By Region
Table 16: Global Inhaled Nitric Oxide Market Share- By Region, 2019 & 2025
8. North America Inhaled Nitric Oxide Market: Segmentation By Product, End Use (2020-2025)
8.1 North America Inhaled Nitric Oxide Market: Size and Forecast (2020-2025)
Table 17: North America Inhaled Nitric Oxide Market Size, By Value, 2015-2025 (USD Million)
Table 18: North America Urban Population, 2014-2018 (% of total)
Table 19: North America Population, 2014–2018 (In Million)
Table 20: North America population aged 65 and above, 2013-2017 (% of total)
Table 21: North America Healthcare Cost Per Capita, 2017 (USD)
Table 22: North America, Smoking Prevalence, Age 15+, 2013-2016
Table 23: North America, PM2.5 air pollution, mean annual exposure (micrograms per cubic meter), 2013-2017
Table 24: United States health care expenditure per capita,2013-2016 (USD)
Table 25: Canada health care expenditure per capita,2013-2016 (USD)
8.2 Market Segmentation By Product Type (99.92% Purity, 99.99% Purity & Others)
Table 26: North America Inhaled Nitric Oxide Market- By Product Type, By Value (USD Million), 2015-2025
8.3 Market Segmentation By Application (ADRS, PPHN & Other Diseases)
Table 27: North America Inhaled Nitric Oxide Market- By Application, By Value (USD Million), 2015-2025
8.4 North America Inhaled Nitric Oxide Market: Country Analysis
8.5 Market Opportunity Chart of North America Inhaled Nitric Oxide Market - By Country, By Value (Year-2025)
Table 28: Market Opportunity Chart of North America Inhaled Nitric Oxide Market - By Country, By Value (Year-2025)
8.6 Competitive Scenario of North America Inhaled Nitric Oxide : By Country
Table 29: North America Inhaled Nitric Oxide Market Share- By Country, 2019 & 2025
8.7 United States Inhaled Nitric Oxide Market: Size and Forecast (2020-2025)
Table 30: United States Inhaled Nitric Oxide Market Size, By Value, 2015-2025 (USD Million)
Table 31: U.S., Per Capita Expenditure on Healthcare, 2012-2018 (In USD)
Table 32: U.S., Population ages 65 and above, 2013-2017 (% of total)
Table 33: U.S., Incidence rate within first two years for neonates/pediatrics, 2018
Table 34: Medical and Healthcare Research & Development Spending, 2013-2016 (In USD Million)
Table 35: United States, PM2.5 air pollution, mean annual exposure (micrograms per cubic meter), 2013-2017
Table 36: United States, Smoking Prevalence, Age 15+, 2012-2016
8.8 United States Inhaled Nitric Oxide Market Segmentation By Product Type, Application
Table 37: Unites States Inhaled Nitric Oxide Market- By Product Type, By Value (USD Million), 2015-2025
Table 38: United States Inhaled Nitric Oxide Market- By Application, By Value (USD Million), 2015-2025
8.9 Canada Inhaled Nitric Oxide Market: Size and Forecast (2020-2025)
Table 39: Canada Inhaled Nitric Oxide Market Size, By Value, 2015-2025 (USD Million)
Table 40: Canada, Expenditure on Health as a share of GDP, 2012-2017 (in %)
Table 41: Canada, Per Capita Healthcare Expenditure, 2012-2017 (USD)
Table 42: Canada, Population ages 65 and above, 2012-2017 (% of total)
Table 43: Percentage Change in Deaths Between, 2007–2017 Due to Respiratory Diseases
Table 44: Canada, PM2.5 air pollution, mean annual exposure (micrograms per cubic meter), 2013-2017
Table 45: Canada, Smoking Prevalence, Age 15+, 2012-2016
Table 46: Number of Retail Pharmacies in Canada, 2013-2017
Table 47: Number of Hospitals Establishments in Canada, By Province, 2015
8.10 Canada Inhaled Nitric Oxide Market Segmentation By Product Type, Application
Table 48: Canada Inhaled Nitric Oxide Market- By Product Type, By Value (USD Million), 2015-2025
Table 49: Canada Inhaled Nitric Oxide Market- By Application, By Value (USD Million), 2015-2025
8.11 Mexico Inhaled Nitric Oxide Market: Size and Forecast (2020-2025)
Table 50: Mexico Inhaled Nitric Oxide Market Size, By Value, 2015-2025 (USD Million)
Table 51: Mexico, PM2.5 air pollution, mean annual exposure (micrograms per cubic meter), 2013-2017
Table 52: Mexico, Smoking Prevalence, Age 15+, 2012-2016
8.12 Mexico Inhaled Nitric Oxide Market Segmentation By Product Type, Application
Table 53: Mexico Inhaled Nitric Oxide Market- By Product Type, By Value (USD Million), 2015-2025
Table 54: Mexico Inhaled Nitric Oxide Market- By Application, By Value (USD Million), 2015-2025
9. Europe Inhaled Nitric Oxide Market: Segmentation By Product, End Use (2020-2025)
9.1 Europe Inhaled Nitric Oxide Market: Size and Forecast (2020-2025)
Table 55: Europe Inhaled Nitric Oxide Market Size, By Value, 2015-2025 (USD Million)
Table 56: European Country Population Aged 65 and Above, 2012-2017 (% of Total)
Table 57: European Union, Population ages 65 and above, 2013-2017 (% of total)
Table 58: European Union, PM2.5 air pollution, mean annual exposure (micrograms per cubic meter), 2013-2017
Table 59: European Union, Smoking Prevalence, Age 15+, 2012-2016
9.2 Market Segmentation By Product Type (99.92% Purity, 99.99% Purity & Others)
Table 60: Europe Inhaled Nitric Oxide Market- By Product Type, By Value (USD Million), 2015-2025
9.3 Market Segmentation By Application (ADRS, PPHN & Other Diseases)
Table 61: Europe Inhaled Nitric Oxide Market- By Application, By Value (USD Million), 2015-2025
9.4 Europe Inhaled Nitric Oxide Market: Country Analysis
9.5 Market Opportunity Chart of Europe Inhaled Nitric Oxide Market - By Country, By Value (Year-2025)
Table 62: Market Opportunity Chart of Europe Inhaled Nitric Oxide Market - By Country, By Value (Year-2025)
9.6 Competitive Scenario of Europe Inhaled Nitric Oxide : By Country
Table 63: Europe Inhaled Nitric Oxide Market Share- By Country, 2019 & 2025
9.7 United Kingdom Inhaled Nitric Oxide Market: Size and Forecast (2020-2025)
Table 64: United Kingdom Inhaled Nitric Oxide Market Size, By Value, 2015-2025 (USD Million)
Table 65: U.K, Health Expenditure, (% of GDP), 2013-2017 (USD)
Table 66: U.K, Population Ages 65 and Above (% of total), 2012-2017
Table 67: U.K, Spending on Healthcare, 2015 & 2040, (USD Per Person)
Table 68: U.K, PM2.5 air pollution, mean annual exposure (micrograms per cubic meter), 2013-2017
Table 69: U.K, Smoking Prevalence (% of Total), 2012-2017
9.8 United Kingdom Inhaled Nitric Oxide Market Segmentation By Product Type, Application
Table 70: U.K Inhaled Nitric Oxide Market- By Product Type, By Value (USD Million), 2015-2025
Table 71: U.K Inhaled Nitric Oxide Market- By Application, By Value (USD Million), 2015-2025
9.9 Italy Inhaled Nitric Oxide Market: Size and Forecast (2020-2025)
Table 72: Italy Inhaled Nitric Oxide Market Size, By Value, 2015-2025 (USD Million)
Table 73: Italy, Health Expenditure, (% of GDP), 2013-2017 (USD)
Table 74: Italy, Population Ages 65 and Above (% of total), 2012-2017
Table 75: Italy, Spending on Healthcare, 2015 & 2040, (USD Per Person)
Table 76: Italy, Smoking Prevalence, Age 15+, 2012-2016
Table 77: Italy, PM2.5 air pollution, mean annual exposure (micrograms per cubic meter) 2013-2017
9.10 Italy Inhaled Nitric Oxide Market Segmentation By Product Type, Application
Table 78: Italy Inhaled Nitric Oxide Market- By Product Type, By Value (USD Million), 2015-2025
Table 79: Italy Inhaled Nitric Oxide Market- By Application, By Value (USD Million), 2015-2025
9.11 Germany Inhaled Nitric Oxide Market: Size and Forecast (2020-2025)
Table 80: Germany Inhaled Nitric Oxide Market Size, By Value, 2015-2025 (USD Million)
Table 81: Germany, Spending on Healthcare, 2015 & 2040E, (USD Per Person)
Table 82: Germany, Population ages 65 and above, 2014-2018 (% total)
Table 83: PM2.5 air pollution, mean annual exposure (micrograms per cubic meter), 2013-2017
Table 84: Germany, Smoking Prevalence, Age 15+, 2012-2016, (% of Total)
9.12 Germany Inhaled Nitric Oxide Market Segmentation By Product Type, Application
Table 85: Germany Inhaled Nitric Oxide Market- By Product Type, By Value (USD Million), 2015-2025
Table 86: Germany Inhaled Nitric Oxide Market- By Application, By Value (USD Million), 2015-2025
9.13 France Inhaled Nitric Oxide Market: Size and Forecast (2020-2025)
Table 87: France Inhaled Nitric Oxide Market Size, By Value, 2015-2025 (USD Million)
Table 88: France, Health Expenditure, (% of GDP), 2012-2015 (USD)
Table 89: France, Population Ages 65 and Above (% of total), 2012-2017
Table 90: France, Cause of Death, 2017, (% of Total)
Table 91: France, Spending on Healthcare, 2015 & 2040, (USD Per Person)
Table 92: France, Smoking Prevalence, Age 15+, 2012-2017, (% of Total)
Table 93: France, PM2.5 air pollution, mean annual exposure (micrograms per cubic meter), 2013-2017
9.14 France Inhaled Nitric Oxide Market Segmentation By Product Type, Application
Table 94: France Inhaled Nitric Oxide Market- By Product Type, By Value (USD Million), 2015-2025
Table 95: France Inhaled Nitric Oxide Market- By Application, By Value (USD Million), 2015-2025
10. APAC Inhaled Nitric Oxide Market: Segmentation By Product, End Use (2020-2025)
10.1 APAC Inhaled Nitric Oxide Market: Size and Forecast (2020-2025)
Table 96: APAC Inhaled Nitric Oxide Market Size, By Value, 2015-2025 (USD Million)
Table 97: GDP Per Capita in APAC, By Select Country, 2016 (In USD)
Table 98: Population ages 65 and above, By Select Country, 2017 (% of total)
Table 99: Men Smoking Prevalence in Asia, 2016, (% of Total Population)
Table 100: East Asia & Pacific, PM2.5 air pollution, mean annual exposure (micrograms per cubic meter), 2012-2016
Table 101: South Asia, PM2.5 air pollution, mean annual exposure (micrograms per cubic meter), 2012-2016
10.2 Market Segmentation By Product Type (99.92% Purity, 99.99% Purity & Others)
Table 102: APAC Inhaled Nitric Oxide Market- By Product Type, By Value (USD Million), 2015-2025
10.3 Market Segmentation By Application (ADRS, PPHN & Other Diseases)
Table 103: APAC Inhaled Nitric Oxide Market- By Application, By Value (USD Million), 2015-2025
10.4 APAC Inhaled Nitric Oxide Market: Country Analysis
10.5 Market Opportunity Chart of APAC Inhaled Nitric Oxide Market - By Country, By Value (Year-2025)
Table 104: Market Opportunity Chart of APAC Inhaled Nitric Oxide Market - By Country, By Value (Year-2025)
10.6 Competitive Scenario of APAC Inhaled Nitric Oxide : By Country
Table 105: APAC Inhaled Nitric Oxide Market Share- By Country, 2019 & 2025
10.7 China Inhaled Nitric Oxide Market: Size and Forecast (2020-2025)
Table 106: China Inhaled Nitric Oxide Market Size, By Value, 2015-2025 (USD Million)
Table 107: China, Smoking Prevalence, Age 15+, % of Total Population, 2012-2016
Table 108: China, PM2.5 air pollution, mean annual exposure (micrograms per cubic meter), 2013-2017
Table 109: China, Population Ages 65 and Above, 2012-2017 (% of total)
Table 110: Beijing annual PM2.5 air pollution levels, 2013-2017, ( in micrograms per cubic meter of air)
Table 111: China Co2 Emissions, 2013-2016 (Billion Metric Tons)
Table 112: China, Total Population, 2013-2021F (In Billion)
10.8 China Inhaled Nitric Oxide Market Segmentation By Product Type, Application
Table 113: China Inhaled Nitric Oxide Market- By Product Type, By Value (USD Million), 2015-2025
Table 114: China Inhaled Nitric Oxide Market- By Application, By Value (USD Million), 2015-2025
10.9 Japan Inhaled Nitric Oxide Market: Size and Forecast (2020-2025)
Table 115: Japan Inhaled Nitric Oxide Market Size, By Value, 2015-2025 (USD Million)
Table 116: Japan, GDP Growth Per Year, 2015-2019F (In %)
Table 117: Japan Healthcare Expenditure Outlook (%)
Table 118: Japan, Population ages 65 and above, 2012-2016 (% of total)
Table 119: Japan, Smoking Prevalence, Age 15+, 2012-2016, (% of Total Prevalence)
Table 120: Japan, PM2.5 air pollution, mean annual exposure (micrograms per cubic meter), 2013-2017
10.10 Japan Inhaled Nitric Oxide Market Segmentation By Product Type, Application
Table 121: Japan Inhaled Nitric Oxide Market- By Product Type, By Value (USD Million), 2015-2025
Table 122: Japan Inhaled Nitric Oxide Market- By Application, By Value (USD Million), 2015-2025
10.11 India Inhaled Nitric Oxide Market: Size and Forecast (2020-2025)
Table 123: India Inhaled Nitric Oxide Market Size, By Value, 2015-2025 (USD Million)
Table 124: India, PM2.5 air pollution, mean annual exposure (micrograms per cubic meter), 2013-2017
Table 125: India, Smoking Prevalence, Age 15+, 2012-2016, (% of Total)
Table 126: India, Population Ages 65 and Above, 2013-2017
10.12 India Inhaled Nitric Oxide Market Segmentation By Product Type, Application
Table 127: India Inhaled Nitric Oxide Market- By Product Type, By Value (USD Million), 2015-2025
Table 128: India Inhaled Nitric Oxide Market- By Application, By Value (USD Million), 2015-2025
11. Global Inhaled Nitric Oxide Market Dynamics
11.1 Global Inhaled Nitric Oxide Market Drivers
11.2 Global Inhaled Nitric Oxide Market Restraints
12. Market Attractiveness
12.1 Market Attractiveness Chart of Global Inhaled Nitric Oxide Market - By Product Type (Year 2025)
Table 129: Market Attractiveness Chart of Global Inhaled Nitric Oxide Market- By Product Type (Year-2025)
12.2 Market Attractiveness Chart of Global Inhaled Nitric Oxide Market - By Application (Year 2025)
Table 130: Market Attractiveness Chart of Global Inhaled Nitric Oxide Market- By Application, (Year-2025)
12.3 Market Attractiveness Chart of Global Inhaled Nitric Oxide Market - By Region, By Value, (Year-2025)
Table 131: Market Attractiveness Chart of Global Inhaled Nitric Oxide Market- By Region, By Value, (Year-2025)
13. Policy and Regulatory Landscape
14. Strategic Analysis
14.1 Inhaled Nitric Oxide Product Development
Table A: Product Development Timeline
14.2 Market Share Analysis
Table 132: Global Inhaled Nitric Oxide Share, By Company (%) (2019)
15. Company Analysis (Business Description, Financial Analysis, Business Strategy)
15.1 Mallinckrodt Pharmaceuticals
Table 133: Mallinckrodt Pharmaceuticals, Net Revenue, 2015-2019 (USD Million)
Table 134: Mallinckrodt Pharmaceuticals, Net Profit/Loss, 2015-2019 (USD Million)
Table 135: Mallinckrodt Pharmaceuticals, Sales By Business Division, 2019 (In %)
Table 136: Mallinckrodt Pharmaceuticals, Sales By Geographic Region, 2018 (%)
Table 137: Mallinckrodt Pharmaceuticals, Net Sales for Specialty Brands By Geography, 2019 (In %)
Table 138: Mallinckrodt Pharmaceuticals, Net Sales for Specialty Brands By Key Products, 2019 (%)
15.2 Air Liquide S.A.
Table 139: Air Liquide S.A., Net Sales, 2016-2019 (In USD Million)
Table 140: Air Liquide S.A., Net Profit, 2016-2019 (In USD Million)
Table 141: Air Liquide S.A., Sales By Business Segment, 2019 (In %)
Table 142: Air Liquide S.A., Sales, Distribution of Gas & Services Revenue By Geography, 2019 (In %)
Table 143: Air Liquide S.A., Net Revenue by Gas & Services Revenue By Activity, 2019 (In %)
15.3 Linde Plc (Praxair Inc.)
Table 144: Linde Plc (Praxair Inc.), Net Sales, 2016-2019 (In USD Million)
Table 145: Linde Plc (Praxair Inc.), Net Profit, 2016-2019 (In USD Million)
Table 146: Linde Plc (Praxair Inc.), By Business Segment, 2019 (In %)
Table 147: Linde Plc (Praxair Inc.), Sales By End Market, 2019 (In %)
Table 148: Linde Plc (Praxair Inc.), Sales By Distribution Mode, 2019 (In %)
15.4 VERO Biotech LLC
15.5 Beyond Air Inc.
Table 149: Beyond Air Inc., Net Revenue, 2015-2019 (In USD Thousands)
Table 150: Beyond Air Inc., Net Profit/Loss, 2015-2018 (In USD Thousands)
15.6 NU-MED Plus, Inc.
Table 151: NU-MED Plus, Inc., Net Profit/Loss, 2015-2019 (In USD Thousands)
15.7 Novoteris LLC

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook